1. Catalogs
  2. WISAP Medical Technology
  3. Cervical Cancer Prevention

Cervical Cancer Prevention

Cervical Cancer Prevention

Cervical Cancer Prevention

Product catalog summary
Overview: The document discusses cervical cancer prevention strategies, focusing on the use of cold coagulation as a treatment method. It highlights the challenges in low- and middle-income countries (LMICs) and compares cold coagulation with cryotherapy.
Primary Prevention: Cervical cancer can be prevented through HPV vaccination, which targets high-risk HPV types responsible for most cervical cancers. However, vaccines do not treat existing infections, necessitating secondary prevention strategies.
Secondary Prevention: Secondary prevention involves detecting and treating pre-cancerous lesions (CIN2+, CIN3, AIS). Effective treatment access is crucial, as many women in some countries do not receive recommended treatments.
Cold Coagulation vs. Cryotherapy: Both methods use temperature to destroy tissue. Cryotherapy uses a cool tip, while cold coagulation uses a hot tip. Cold coagulation is advantageous due to its ease of use, no need for anesthesia, and lower running costs.
Cold Coagulation Procedure: The device heats a probe to 100°C, which is applied to the lesion for 60 seconds. The procedure is simple, fast, and can be performed by various healthcare providers without anesthesia.
Clinical Efficacy: Studies show high cure rates for CIN1, CIN2, and CIN3 lesions treated with cold coagulation. The method is effective, with low pain and bleeding scores.
Technical Specifications: The cold coagulator is lightweight, easy to transport, and operates on standard power. It offers a range of temperatures and is designed for ease of use in diverse settings.
Customer Feedback: Testimonials from healthcare providers in various countries praise the device's reliability, ease of use, and effectiveness in treating cervical lesions.
Conclusion: Cold coagulation is a promising tool for cervical cancer prevention, especially in LMICs, due to its simplicity, cost-effectiveness, and high efficacy.
See more

Catalog excerpts

Cervical Cancer Prevention-1

COLD COAGULATOR Device for Cervical Cancer Prevention WHAT IS THE DIFFERENCE BETWEEN COLD COAGULATION AND CRYOTHERAPY? CLINICAL BACKGROUND Both systems use temperature to destroy tissue and so both are considered to be ablative treatment methods. Cryotherapy uses a cool tip (below -50 °C) to destroy abnormal tissue. Cold coagulation on the other hand uses a hot tip. In high-resource settings, we are fighting cervical cancer quite successfully. In these settings, secondary prevention with cervical cytology linked with timely treatment of precancer has led to considerable declines in mortality. However, cervical cancer is still a major killer of women worldwide, with nearly 90% of new cases diagnosed in low- and middle-income countries (LMICs). Unlike many other cancers, there are primary prevention strategies for cervical cancer that can lead to decreased incidence. Finding out that the human papillomavirus (HPV) is the cause of cervical cancer has led to revolutionary prevention strategies such as prophylactic HPV vaccination, which are effective against seven high-risk HPV types responsible for causing approximately 90% of cervical cancers worldwide. Unfortunately, prophylactic HPV vaccines do not treat pre-existing HPV infections and related conditions. Thus, even if HPV vaccines were immediately distributed worldwide, two to three generations of currently HPV-positive women would not benefit from them. Furthermore, since only a small percentage of women are presently vaccinated, mortality will hardly decrease in the next couple of years. Secondary prevention strategies for the detection and treatment of precancerous lesions are needed for the foreseeable future. Pre-cancer is defined as cervical intraepithelial neoplasia grade 2 [CIN2], grade 3 [CIN3] and adenocarcinoma in situ [AIS], together “CIN2+”. Regardless of screening strategy, access to effective treatment for women with cervical precancer is crucial. In some countries, up to 80% of women diagnosed with cervical pre-cancer do not receive the recommended treatment. Therefore it is crucial to implement a clinically tested and highly efficacious treatment method, which is easy to handle and cheap to run.

 Open the catalog to page 1
Cervical Cancer Prevention-2

CERVICAL CANCER PREVENTIONin low- and middle-income countries HOW DOES COLD COAGULATION WORK? The treatment method of a thermo tip can be compared to the properties of a pan, used for cooking. The thermo tip is electrically heated to up to 100 °C. The tissue is destroyed by heat. The device controls the temperature to remain at the pre-set temperature for the duration of the treatment. The probe has an anti-stick surface to make sure that no tissue will be stuck when retracting the probe from the cervix at the end of the treatment. Cold coagulation cannot be compared to HF coagulation though....

 Open the catalog to page 2
Cervical Cancer Prevention-3

COLD COAGULATOR Device for Cervical Cancer Prevention Customer Feedback Dr. Miriam Cremer MD/MPH, “I believe that because of the devices simplicity the Cold Coagulator has the potential to be a global game-changer in the field of cervical cancer prevention.” www.basichealth.org DAEYANG LUKE HOSPITAL LILONGWE, MALAWI “At our mission hospital we have been using the WISAP cold coagulator for about a year and a half. We are very pleased with the performance, reliability and ease of use of this instrument. I can easily carry it with me to other hospitals where I offer gynecologic consultations. This...

 Open the catalog to page 3
Cervical Cancer Prevention-4

Device for Cervical Cancer Prevention Cold Coagulation Ablation of cervical lesions by „boiling“ of tissue Contact and order If you need any additional information, we are happy to help you. Please get in touch with our customer service: Phone: 0049 8104 89 08 0 eMail: [email protected] Fast Procedure (20 - 60 seconds) • Low temperature treatment (60-120°C) • No local anesthesia required • No tissue scarring • Low pain scores • Low bleeding events • Low watery discharge

 Open the catalog to page 4

All WISAP Medical Technology catalogs and technical brochures

  1. INSUFFLATION

    12  Pages

  2. VISUALIZATION

    24  Pages

  3. Instruments

    44  Pages

  4. Morcellation

    10  Pages

  5. Gynecology

    26  Pages

*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.